Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy
![Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy | Nature Communications Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-27461-8/MediaObjects/41467_2021_27461_Fig1_HTML.png)
Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy | Nature Communications
![PDF) Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy PDF) Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy](https://www.researchgate.net/profile/Chantal-Van-Opbergen/publication/356907714/figure/fig8/AS:1099334087114768@1639113079394/Istaroxime-reverses-action-potential-alternans-in-plna-R14del-isolated-adult_Q320.jpg)
PDF) Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy
![IJMS | Free Full-Text | Gap19, a Cx43 Hemichannel Inhibitor, Acts as a Gating Modifier That Decreases Main State Opening While Increasing Substate Gating IJMS | Free Full-Text | Gap19, a Cx43 Hemichannel Inhibitor, Acts as a Gating Modifier That Decreases Main State Opening While Increasing Substate Gating](https://pub.mdpi-res.com/ijms/ijms-21-07340/article_deploy/html/images/ijms-21-07340-g001-550.jpg?1601874435)
IJMS | Free Full-Text | Gap19, a Cx43 Hemichannel Inhibitor, Acts as a Gating Modifier That Decreases Main State Opening While Increasing Substate Gating
![IJMS | Free Full-Text | Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis IJMS | Free Full-Text | Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis](https://www.mdpi.com/ijms/ijms-23-06947/article_deploy/html/images/ijms-23-06947-g001.png)